title: Production of cyclooxygenase products and superoxide anion by macrophages in response to chemotactic factors.
abstract: Mononuclear phagocytes are known to play a key role in various phlogistic reactions by synthesizing and releasing products that may potentiate or inhibit inflammatory processes. The expression of these products appears to be dependent on the source of the macrophage population as well as the stimulus employed. We have studied superoxide anion (O-2) production as well as the generation of PGE2, PGF2 alpha, and TXB2 from resident, oil-elicited and thioglycollate-induced peritoneal macrophages in mice in the presence and absence of chemotactic peptides. Production of O-2, occurred only in elicited macrophages stimulated with high concentrations of FMLP or C5a; resident cells stimulated with either of the chemotactic peptides were completely unresponsive. Although resident peritoneal macrophages incubated with chemotactic peptides did not generate O-2, these cells did secrete significant levels of PGE2, PGF2 alpha, and TXB2 in response to C5a. FMLP had no stimulatory effect. Elicited macrophages generated increased levels of PGE2 and PGF2 alpha when incubated with C5a. However, production of TXB2 was not stimulated. FMLP was inactive in stimulating PGE2, PGF2 alpha, and TXB2 in all types of macrophages studied. These studies indicate a heterogeneity in the production of inflammatory mediators from various macrophage populations in response to chemotactic factors.
mesh_terms: D000818:Animals; D000838:Anions; D001202:Ascitic Fluid / Q000166:cytology; D002478:Cells, Cultured; D002630:Chemotactic Factors / Q000494:pharmacology*; D003182:Complement C5 / Q000494:pharmacology; D015936:Complement C5a; D015237:Dinoprost; D015232:Dinoprostone; D005260:Female; D008264:Macrophages / Q000378:metabolism*; D051379:Mice; D008808:Mice, Inbred CBA; D009239:N-Formylmethionine / Q000031:analogs & derivatives / Q000494:pharmacology; D009240:N-Formylmethionine Leucyl-Phenylalanine; D009842:Oligopeptides / Q000494:pharmacology; D010100:Oxygen / Q000378:metabolism*; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism*; D011458:Prostaglandins E / Q000096:biosynthesis; D011460:Prostaglandins F / Q000096:biosynthesis; D013481:Superoxides / Q000378:metabolism*; D013929:Thromboxane B2 / Q000096:biosynthesis
chemical_list: D000838:Anions; D002630:Chemotactic Factors; D003182:Complement C5; D009842:Oligopeptides; D011458:Prostaglandins E; D011460:Prostaglandins F; D013481:Superoxides; D009239:N-Formylmethionine; D013929:Thromboxane B2; D009240:N-Formylmethionine Leucyl-Phenylalanine; D015936:Complement C5a; D015237:Dinoprost; D011451:Prostaglandin-Endoperoxide Synthases; D015232:Dinoprostone; D010100:Oxygen